Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The Cost-effectiveness of Welcome to Medicare Visual Acuity Screening and a Possible Alternative Welcome to Medicare Eye Evaluation Among Persons Without Diagnosed Diabetes Mellitus.
Rein DB, Wittenborn JS, Zhang X, Hoerger TJ, Zhang P, Klein BE, Lee KE, Klein R, Saaddine JB.
Arch Ophthalmol. 2012 Jan 9. [Epub ahead of print]
Related citations
Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular edema.
Sun JK, Qin H, Aiello LP, Melia M, Beck RW, Andreoli CM, Edwards PA, Glassman AR, Pavlica MR; Diabetic Retinopathy Clinical Research Network.
Arch Ophthalmol. 2012 Apr;130(4):470-9. Epub 2011 Dec 12.
Treatment of proliferative diabetic retinopathy using viscosurgery with vital dye.
Nadal J, Capella MJ.
Arch Ophthalmol. 2011 Oct;129(10):1358-60.
Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
Ebneter A, Chidlow G, Wood JP, Casson RJ.
Arch Ophthalmol. 2011 Oct;129(10):1337-44.
Early diabetes mellitus or hypertension is not significantly associated with severity of vision loss in nonarteritic anterior ischemic optic neuropathy.
Odette JD, Okorodudu DO, Johnson LN.
Arch Ophthalmol. 2011 Aug;129(8):1106-7. No abstract available.
Frequency of intraocular pressure increase within days after intravitreal triamcinolone injections in the diabetic retinopathy clinical research network.
Lauer AK, Bressler NM, Edwards AR; Diabetic Retinopathy Clinical Research Network.
Arch Ophthalmol. 2011 Aug;129(8):1097-9. No abstract available.
Use of eye care services among diabetic patients in urban Indonesia.
Adriono G, Wang D, Octavianus C, Congdon N.
Arch Ophthalmol. 2011 Jul;129(7):930-5. Erratum in: Arch Ophthalmol. 2011 Oct;129(10):1372.
The microperimetry of resolved cotton-wool spots in eyes of patients with hypertension and diabetes mellitus.
Kim JS, Maheshwary AS, Bartsch DU, Cheng L, Gomez ML, Hartmann K, Freeman WR.
Arch Ophthalmol. 2011 Jul;129(7):879-84.
Importance of the NHANES 2005-2008 diabetic retinopathy data.
Frank RN.
Arch Ophthalmol. 2011 Jun;129(6):788-90. No abstract available.
Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.
Arch Ophthalmol. 2011 Jun;129(6):718-26.
New viscodissection instrument for use with microincisional vitrectomy in the treatment of diabetic tractional retinal detachments.
Fortun JA, Hubbard GB 3rd.
Arch Ophthalmol. 2011 Mar;129(3):352-5.
Telemedicine and diabetic retinopathy: moving beyond retinal screening.
Silva PS, Cavallerano JD, Aiello LM, Aiello LP.
Arch Ophthalmol. 2011 Feb;129(2):236-42.
An integrated approach to diabetic retinopathy research.
Gardner TW, Abcouwer SF, Barber AJ, Jackson GR.
Arch Ophthalmol. 2011 Feb;129(2):230-5. Review.
The burgeoning public health impact of diabetes: the role of the ophthalmologist.
Beck RW.
Arch Ophthalmol. 2011 Feb;129(2):225-9.
Diabetes mellitus and early age-related macular degeneration.
Choi JK, Lym YL, Moon JW, Shin HJ, Cho B.
Arch Ophthalmol. 2011 Feb;129(2):196-9.
Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.
Massin P, Lange C, Tichet J, Vol S, Erginay A, Cailleau M, Eschwège E, Balkau B; DESIR (Data From an Epidemiological Study on the Insulin Resistance Syndrome) Study Group.
Arch Ophthalmol. 2011 Feb;129(2):188-95.
Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Yamaji H, Shiraga F, Shiragami C, Nomoto H, Fujita T, Fukuda K.
Arch Ophthalmol. 2011 Jan;129(1):106-7. No abstract available.
Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape.
Wong TY.
Arch Ophthalmol. 2011 Jan;129(1):95-6. No abstract available.
Refraction in adults with diabetes.
Klein BE, Lee KE, Klein R.
Arch Ophthalmol. 2011 Jan;129(1):56-62.
Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus.
Roy MS, Klein R, Janal MN.
Arch Ophthalmol. 2011 Jan;129(1):8-15.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on